One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

On Wednesday, Thermo Fisher Scientific Inc. (NYSE: TMO) posted third-quarter revenue of $10.59 billion, almost flat year over ...

a lab-built miniature version of the gene mutated in the disease. But the results could also pose a much broader problem, STAT’s Jason Mast and Adam Feuerstein write. The Food and Drug ...

Novo Nordisk's once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial. Write to Rob Curran at ...

Finally, a “good” side-effect! People are lining up to get on the Ozempic train, and they don’t care how much it costs ...

A high-profile research project from DTU is among the first six projects that have made it through the eye of the needle and ...

Laboratory operator Labcorp beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for ...

The life sciences industry drives innovation, but environmental considerations must be incorporated from the beginning.

Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...

Trader's laboratory, combines proprietary methods ... that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve ...